Funding for this research was provided by:
Natural Science Foundation of Shanghai (19ZR1410600)
Text and Data Mining valid from 2019-11-29
Received: 3 September 2019
Accepted: 14 November 2019
First Online: 29 November 2019
Ethics approval and consent to participate
: This study was undertaken in accordance with the ethical standards of the World Medical Association Declaration of Helsinki. The trial protocol was approved by the Institutional Review Board on Medical Ethics at Fudan University Shanghai Cancer Center, and was registered at ClinicalTrials.gov (NCT 01064999). All study participants provided written informed consent prior to treatment.
: Not applicable.
: The authors declare that they have no competing interests.